Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Innovotech Inc V.IOT

Innovotech Inc. is a Canada-based biotechnology company. The Company is engaged in owning intellectual property, conducting contract research, and owning and providing devices for testing in multiple applications in microbiology. Its contract research services include Antimicrobial Contract Research; Antimicrobial and Anti-Biofilm Agents, including Minimum Inhibitory Concentration (MIC) and Minimum Biofilm; Eradication Concentration (MBEC); Antimicrobial and Anti-Biofilm Materials, including TM100, ISO 22196 and USP 51; Customized Antimicrobial Testing, including BEST Assay Testing and Implanted Medical Device Testing; Bacteriophage Testing; and Analytical Capabilities. It also offers MBEC Assay Kits, Order Biofilm Assays and Coated MBEC Assay Lids. Its biofilm research includes The Science of Biofilms, Biofilm Publications and SEM Library. Its antimicrobial silver products include AgreGuard-1 Silver Antimicrobial for Crop Protection and InnovoSIL Antimicrobial Silver Products.


TSXV:IOT - Post by User

Post by overnouton Jan 18, 2021 9:37am
191 Views
Post# 32318739

Curious Deal Action

Curious Deal ActionNot sure what to make of this.

Edmonton -TheNewswire -January 18th, 2021 -  Innovotech Inc. (TSXV:IOT), (the “Company”), and Lonsdale Capital Corporation (“Lonsdale”) have terminated the agreement announced January 04, 2021 for the acquisition by the Company of shares of listed health sector companies held by Lonsdale.

“The transaction has not formally closed, pending regulatory approval, and in the mutual interests of Innovotech Inc. and Lonsdale Capital Corporation, Lonsdale has withdrawn its offer” said Alan Savage, CFO of Innovotech and President of Lonsdale.

<< Previous
Bullboard Posts
Next >>